Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Wohlfahrt

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Advances in Cancer Research|June 28, 2011
Faulty epithelial polarity genes and cancerTopi A Tervonen, Johanna I Partanen, Sirkku T Saarikoski, et al.
Scientific Reports|July 4, 2015
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapiesAnu-Maarit Moilanen, Reetta Riikonen, Riikka Oksala, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approachRajeev Goswami, Gerd Wohlfahrt, Subhendu Mukherjee, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase InhibitorsRajeev Goswami, Subhendu Mukherjee, Gerd Wohlfahrt, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 14, 2018
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1Riikka Oksala, Anu Moilanen, Reetta Riikonen, et al.
Molecular Cancer Therapeutics|September 21, 2022
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone BiosynthesisMari Karimaa, Reetta Riikonen, Henna Kettunen, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2015
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitorsRajeev Goswami, Gerd Wohlfahrt, Olli Törmäkangas, et al.
Bioorganic & Medicinal Chemistry|May 6, 2014
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacyRajeev Goswami, Subhendu Mukherjee, Chakshusmathi Ghadiyaram, et al.
Journal of the American Chemical Society|August 22, 2002
The active site of cellobiohydrolase Cel6A from Trichoderma reesei: the roles of aspartic acids D221 and D175Anu Koivula, Laura Ruohonen, Gerd Wohlfahrt, et al.
Journal of Medicinal Chemistry|February 21, 2023
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21Fabian Göricke, Victoria Vu, Leanna Smith, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Advances in Cancer Research|June 28, 2011
Faulty epithelial polarity genes and cancerTopi A Tervonen, Johanna I Partanen, Sirkku T Saarikoski, et al.
Scientific Reports|July 4, 2015
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapiesAnu-Maarit Moilanen, Reetta Riikonen, Riikka Oksala, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approachRajeev Goswami, Gerd Wohlfahrt, Subhendu Mukherjee, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase InhibitorsRajeev Goswami, Subhendu Mukherjee, Gerd Wohlfahrt, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 14, 2018
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1Riikka Oksala, Anu Moilanen, Reetta Riikonen, et al.
Molecular Cancer Therapeutics|September 21, 2022
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone BiosynthesisMari Karimaa, Reetta Riikonen, Henna Kettunen, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2015
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitorsRajeev Goswami, Gerd Wohlfahrt, Olli Törmäkangas, et al.
Bioorganic & Medicinal Chemistry|May 6, 2014
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacyRajeev Goswami, Subhendu Mukherjee, Chakshusmathi Ghadiyaram, et al.
Journal of the American Chemical Society|August 22, 2002
The active site of cellobiohydrolase Cel6A from Trichoderma reesei: the roles of aspartic acids D221 and D175Anu Koivula, Laura Ruohonen, Gerd Wohlfahrt, et al.
Journal of Medicinal Chemistry|February 21, 2023
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21Fabian Göricke, Victoria Vu, Leanna Smith, et al.
Pageof 4